In some cases melanoma can be a fatal disease for patients, which makes gaining as much knowledge about it as possible a critical task for medical science.
MRV Research
Gene Expression Profile Improves Melanoma Risk Assessment
Medical Research Interview with Pedram Gerami, M.D. on Gene Expression Profile Improves Melanoma Risk Assessment
Explainer: how does Keytruda treat melanoma and why is it so costly?
Keytruda® (pembrolizumab) is the latest drug to be registered in Australia for the treatment of widespread melanoma. This is the third class of drugs that improves survival in widespread melanoma to be registered since July 2011. Prior to this no chemotherapy drug prolonged survival once melanoma had spread.
Combined Adaptive and Innate Immunity Stops Tumor Growth in Severe Melanoma Models
In a new study entitled “Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2,” researchers show how combining both innate and adaptive immune strategies in immunotherapy boosts anti-tumor activity and prevents tumor re-formation. The study was published in the journal Cancer Cell.